Hospital Universitario La Paz - Oncology Department

Madrid

0 studies enrolling now · 2 studies all time

What they study most

Head and Neck Cancer, Non-Small Cell Lung Cancer

Studies at this site

• Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322) — Running, not enrolling
• Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION) — Stopped early